Efficacy and Safety of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis
Clinical trial NCT01359566 · COMPLETED
Trial details
- NCT number
- NCT01359566
- Sponsor
- XenoPort, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-05-01
- Primary completion
- 2013-02-01
- Enrollment
- 228
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.